Skip to main content

18.05.2017 | Overactive Bladder (U Lee, Section Editor) | Ausgabe 4/2017

Current Bladder Dysfunction Reports 4/2017

The Role of Oral Contraception on Bladder Symptoms

Current Bladder Dysfunction Reports > Ausgabe 4/2017
Lauren N. Wood, Tamara Grisales
Wichtige Hinweise
This article is part of the Topical Collection on Overactive Bladder


Purpose of Review

While the effects of local and systemic estrogen on the pelvic floor have been widely studied in postmenopausal women, little is known about oral contraceptive (OCP) use and the role on bladder symptoms. Estrogen and progesterone have been implicated in both the treatment and etiology of various pelvic floor conditions including overactive bladder, urinary incontinence, recurrent urinary tract infections, and interstitial cystitis/bladder pain syndrome. This article will review the effect of oral contraceptive pills on bladder symptoms.

Recent Findings

Oral contraceptives appear to decrease the risk of stress urinary incontinence (SUI). The effect of OCP on recurrent UTI, OAB/UUI is unclear. Combined oral contraceptives may be implicated in interstitial cystitis/bladder pain syndrome.


There appears to be a link between changes in estrogen and progesterone levels and lower urinary tract symptoms. While many studies have evaluated the effect of hormones on the genitourinary tract and bladder function in postmenopausal women menopause, further studies are needed to directly examine the role of OCP in the etiology and treatment of various lower urinary tract conditions. Oral contraceptives are manufactured with a variety of synthetic progestins and with varying dosages of estrogen and progestin, which have been demonstrated to alter endogenous hormone production and hormone receptor expression. Further research how these changes may affect bladder function is warranted.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf

Weitere Produktempfehlungen anzeigen
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2017

Current Bladder Dysfunction Reports 4/2017 Zur Ausgabe

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Risk Factors for Infection Following Third-line Therapy for Overactive Bladder

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Long-Term Voiding Outcomes After Adult Urethral Reconstruction for Stricture Disease

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Impact of Autonomic Dysfunction on Lower Urinary Tract Symptoms

  1. Sie können e.Med Gynäkologie & Urologie 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

Neu im Fachgebiet Urologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Urologie und bleiben Sie gut informiert – ganz bequem per eMail.